| Calhoun Health Care Center | |
| 1387 Highway 41 North, Calhoun, Georgia 30701 | |
| (706) 629-1289 | |
| Name | Calhoun Health Care Center |
|---|---|
| Location | 1387 Highway 41 North, Calhoun, Georgia |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 100 |
| Occupancy Rate | 70.3% |
| Medicare ID (CCN) | 115340 |
| Legal Business Name | Gacalhoun Snf Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1548745342 |
| Organization Name | GACALHOUN SNF LLC |
| Doing Business As | CALHOUN HEALTH CARE CENTER |
| Address | 1387 Highway 41 N., Calhoun, GA 30701 |
| Phone Number | 706-629-1289 |
News Archive
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
The 25th Africa-France Summit, a two-day gathering "aimed at developing better business relations between" the regions, began Monday in the French city of Nice, All Headline News reports.
In an ongoing effort to scientifically validate the age-old belief that mind-body interventions have a beneficial impact on the health of patients, The University of Texas M. D. Anderson Cancer Center has been awarded more than $4.5 million to study the efficacy of incorporating yoga into the treatment program of women with breast cancer.
In another major courtroom verdict linking powerful acne medication Accutane with long-term inflammatory bowel disease (IBD), a nine-person New Jersey jury has found that pharmaceutical maker Hoffman-La Roche Inc. failed to provide an adequate warning of the possible condition to Andrew McCarrell's prescribing physician, which then led to his development of chronic IBD. Mr. McCarrell, who was 23 at the time he took Accutane, developed a severe case of IBD and thereafter had his colon removed. The jury awarded compensatory damages of $25.16 million to Andy, now in his thirties.
There is a lot of press coverage about the VA proposed rule to allow advanced practice registered nurses, including Certified Registered Nurse Anesthetists, to practice to the full scope of their education, training, and licensure in the Veterans Health Administration.
› Verified 4 days ago
| NPI Number | 1649701434 |
| Organization Name | CPLACE CALHOUN SNF LLC |
| Doing Business As | CALHOUN HEALTH CARE CENTER |
| Address | 1387 Highway 41 North, Calhoun, GA 30701 |
| Phone Number | 706-629-1289 |
News Archive
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
The 25th Africa-France Summit, a two-day gathering "aimed at developing better business relations between" the regions, began Monday in the French city of Nice, All Headline News reports.
In an ongoing effort to scientifically validate the age-old belief that mind-body interventions have a beneficial impact on the health of patients, The University of Texas M. D. Anderson Cancer Center has been awarded more than $4.5 million to study the efficacy of incorporating yoga into the treatment program of women with breast cancer.
In another major courtroom verdict linking powerful acne medication Accutane with long-term inflammatory bowel disease (IBD), a nine-person New Jersey jury has found that pharmaceutical maker Hoffman-La Roche Inc. failed to provide an adequate warning of the possible condition to Andrew McCarrell's prescribing physician, which then led to his development of chronic IBD. Mr. McCarrell, who was 23 at the time he took Accutane, developed a severe case of IBD and thereafter had his colon removed. The jury awarded compensatory damages of $25.16 million to Andy, now in his thirties.
There is a lot of press coverage about the VA proposed rule to allow advanced practice registered nurses, including Certified Registered Nurse Anesthetists, to practice to the full scope of their education, training, and licensure in the Veterans Health Administration.
› Verified 4 days ago
| NPI Number | 1710953682 |
| Organization Name | CALHOUN HEALTH CARE CENTER, INC |
| Address | 1387 Highway 41 North, Calhoun, GA 30701 |
| Phone Number | 706-629-1289 |
News Archive
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
The 25th Africa-France Summit, a two-day gathering "aimed at developing better business relations between" the regions, began Monday in the French city of Nice, All Headline News reports.
In an ongoing effort to scientifically validate the age-old belief that mind-body interventions have a beneficial impact on the health of patients, The University of Texas M. D. Anderson Cancer Center has been awarded more than $4.5 million to study the efficacy of incorporating yoga into the treatment program of women with breast cancer.
In another major courtroom verdict linking powerful acne medication Accutane with long-term inflammatory bowel disease (IBD), a nine-person New Jersey jury has found that pharmaceutical maker Hoffman-La Roche Inc. failed to provide an adequate warning of the possible condition to Andrew McCarrell's prescribing physician, which then led to his development of chronic IBD. Mr. McCarrell, who was 23 at the time he took Accutane, developed a severe case of IBD and thereafter had his colon removed. The jury awarded compensatory damages of $25.16 million to Andy, now in his thirties.
There is a lot of press coverage about the VA proposed rule to allow advanced practice registered nurses, including Certified Registered Nurse Anesthetists, to practice to the full scope of their education, training, and licensure in the Veterans Health Administration.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
The 25th Africa-France Summit, a two-day gathering "aimed at developing better business relations between" the regions, began Monday in the French city of Nice, All Headline News reports.
In an ongoing effort to scientifically validate the age-old belief that mind-body interventions have a beneficial impact on the health of patients, The University of Texas M. D. Anderson Cancer Center has been awarded more than $4.5 million to study the efficacy of incorporating yoga into the treatment program of women with breast cancer.
In another major courtroom verdict linking powerful acne medication Accutane with long-term inflammatory bowel disease (IBD), a nine-person New Jersey jury has found that pharmaceutical maker Hoffman-La Roche Inc. failed to provide an adequate warning of the possible condition to Andrew McCarrell's prescribing physician, which then led to his development of chronic IBD. Mr. McCarrell, who was 23 at the time he took Accutane, developed a severe case of IBD and thereafter had his colon removed. The jury awarded compensatory damages of $25.16 million to Andy, now in his thirties.
There is a lot of press coverage about the VA proposed rule to allow advanced practice registered nurses, including Certified Registered Nurse Anesthetists, to practice to the full scope of their education, training, and licensure in the Veterans Health Administration.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $12688 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 10.76 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 4.55 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 21.15 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.98 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.81 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 73.33 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 6.82 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 19.7 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 18.11 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 9.33 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 5.8 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 16.55 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 27.12 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 13.53 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 90.68 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 85.76 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 20.14 | 82.93 |
News Archive
Intellect Neurosciences, Inc a biopharmaceutical company with an internal preclinical and clinical-stage pipeline and licenses with major pharmaceutical companies covering products in late-stage clinical trials, announced that it has received a Notice of Allowance from the United States Patent and Trademark Office related to RV01 and RV02, the Company's two lead vaccine candidates. The Notice of Allowance is a written communication stating that the patent application has been allowed and will be granted as a new patent. RV01 and RV02, generated using the Company's RECALL-VAX technology, have the potential to delay the onset of or prevent Alzheimer's disease in individuals susceptible by age, genetic or other risk factor.
The 25th Africa-France Summit, a two-day gathering "aimed at developing better business relations between" the regions, began Monday in the French city of Nice, All Headline News reports.
In an ongoing effort to scientifically validate the age-old belief that mind-body interventions have a beneficial impact on the health of patients, The University of Texas M. D. Anderson Cancer Center has been awarded more than $4.5 million to study the efficacy of incorporating yoga into the treatment program of women with breast cancer.
In another major courtroom verdict linking powerful acne medication Accutane with long-term inflammatory bowel disease (IBD), a nine-person New Jersey jury has found that pharmaceutical maker Hoffman-La Roche Inc. failed to provide an adequate warning of the possible condition to Andrew McCarrell's prescribing physician, which then led to his development of chronic IBD. Mr. McCarrell, who was 23 at the time he took Accutane, developed a severe case of IBD and thereafter had his colon removed. The jury awarded compensatory damages of $25.16 million to Andy, now in his thirties.
There is a lot of press coverage about the VA proposed rule to allow advanced practice registered nurses, including Certified Registered Nurse Anesthetists, to practice to the full scope of their education, training, and licensure in the Veterans Health Administration.
› Verified 4 days ago
Calhoun Health Care Center Location: 1387 Highway 41 North, Calhoun, Georgia 30701 Phone: (706) 629-1289 | |
Gordon Health And Rehabilitation Location: 1280 Mauldin Road Ne, Calhoun, Georgia 30703 Phone: (706) 625-0044 |